148 related articles for article (PubMed ID: 6502494)
1. Oral and intravenous pharmacokinetics of milrinone in human volunteers.
Stroshane RM; Koss RF; Biddlecome CE; Luczkowec C; Edelson J
J Pharm Sci; 1984 Oct; 73(10):1438-41. PubMed ID: 6502494
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of the bipyridines amrinone and milrinone.
Edelson J; Stroshane R; Benziger DP; Cody R; Benotti J; Hood WB; Chatterjee K; Luczkowec C; Krebs C; Schwartz R
Circulation; 1986 Mar; 73(3 Pt 2):III145-52. PubMed ID: 3510771
[TBL] [Abstract][Full Text] [Related]
3. Oral bioavailability and intravenous pharmacokinetics of amrinone in humans.
Park GB; Kershner RP; Angellotti J; Williams RL; Benet LZ; Edelson J
J Pharm Sci; 1983 Jul; 72(7):817-9. PubMed ID: 6886991
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of piroximone (MDL 19.205) in healthy volunteers.
Haegele KD; Belz GG; Meinicke TT; Schechter PJ
Eur J Clin Pharmacol; 1986; 31(2):239-42. PubMed ID: 3803422
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of milrinone in chronic congestive heart failure.
Benotti JR; Lesko LJ; McCue JE; Alpert JS
Am J Cardiol; 1985 Oct; 56(10):685-9. PubMed ID: 4050707
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of milrinone lactate in pediatric patients with septic shock.
Lindsay CA; Barton P; Lawless S; Kitchen L; Zorka A; Garcia J; Kouatli A; Giroir B
J Pediatr; 1998 Feb; 132(2):329-34. PubMed ID: 9506650
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and effects on blood pressure of a single oral dose of milrinone in healthy subjects and in patients with renal impairment.
Larsson R; Liedholm H; Andersson KE; Keane MA; Henry G
Eur J Clin Pharmacol; 1986; 29(5):549-53. PubMed ID: 3956560
[TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects.
Wiesel FA; Alfredsson G; Ehrnebo M; Sedvall G
Eur J Clin Pharmacol; 1980 May; 17(5):385-91. PubMed ID: 7418717
[TBL] [Abstract][Full Text] [Related]
9. Dose regimen adjustment for milrinone in congestive heart failure patients with moderate and severe renal failure.
Woolfrey SG; Hegbrant J; Thysell H; Fox PA; Lendrem DW; Lockwood GF; Lasher K; Rogers J; Greenslade D
J Pharm Pharmacol; 1995 Aug; 47(8):651-5. PubMed ID: 8583366
[TBL] [Abstract][Full Text] [Related]
10. The absolute oral bioavailability and population-based pharmacokinetic modelling of a novel dipeptidylpeptidase-IV inhibitor, vildagliptin, in healthy volunteers.
He YL; Sadler BM; Sabo R; Balez S; Wang Y; Campestrini J; Laurent A; Ligueros-Saylan M; Howard D
Clin Pharmacokinet; 2007; 46(9):787-802. PubMed ID: 17713976
[TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacokinetics and pharmacodynamics of intravenous and oral nefopam in healthy volunteers.
Aymard G; Warot D; Démolis P; Giudicelli JF; Lechat P; Le Guern ME; Alquier C; Diquet B
Pharmacol Toxicol; 2003 Jun; 92(6):279-86. PubMed ID: 12787260
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic properties of ethosuximide in monkeys. I. Single-dose intravenous and oral administration.
Patel IH; Levy RH; Bauer TG
Epilepsia; 1975 Dec; 16(5):705-16. PubMed ID: 816644
[TBL] [Abstract][Full Text] [Related]
13. [Human pharmacokinetics of theophylline and etofylline from different formulations of a cardiotonic (author's transl)].
Erking W; Lücker PW; Niebch G; Thiemer K; Wetzelsberger K
Arzneimittelforschung; 1981; 31(2):371-9. PubMed ID: 7194656
[TBL] [Abstract][Full Text] [Related]
14. Absolute bioavailability of chlorthalidone in man: a cross-over study after intravenous and oral administration.
Fleuren HL; Thien TA; Verwey-van Wissen CP; van Rossum JM
Eur J Clin Pharmacol; 1979 Feb; 15(1):35-50. PubMed ID: 421727
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of bolus intravenous and oral doses of L-carnitine in healthy subjects.
Harper P; Elwin CE; Cederblad G
Eur J Clin Pharmacol; 1988; 35(1):69-75. PubMed ID: 3220097
[TBL] [Abstract][Full Text] [Related]
16. Correlation of the hemodynamic and pharmacokinetic profile of intravenous milrinone in the anesthetized dog.
Alousi AA; Iwan T; Edelson J; Biddlecome C
Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):59-66. PubMed ID: 6721624
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of terodiline in human volunteers.
Karlén B; Andersson KE; Ekman G; Strömberg S; Ulmsten U
Eur J Clin Pharmacol; 1982; 23(3):267-70. PubMed ID: 7173296
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of deramciclane, a novel anxiolytic agent, after intravenous and oral administration.
Huupponen R; Paija O; Salonen M; Björklund H; Rouru J; Anttila M
Drugs R D; 2003; 4(6):339-45. PubMed ID: 14584962
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration.
Rawlins MD; Henderson DB; Hijab AR
Eur J Clin Pharmacol; 1977 Apr; 11(4):283-6. PubMed ID: 862649
[TBL] [Abstract][Full Text] [Related]
20. Milrinone, a new agent for the treatment of congestive heart failure.
Hasegawa GR
Clin Pharm; 1986 Mar; 5(3):201-5. PubMed ID: 3514085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
